Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response

Among TNBC patients treated with neoadjuvant chemotherapy, NpCR occurs more frequently than BpCR. These findings provide a descriptive overview of current response patterns and may inform future research exploring the safety of omitting axillary surgical evaluation. Factors beyond tumor subtype likely influence response patterns, indicating the need for further research to identify predictive biomarkers and optimize treatment strategies.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Oncology
Published
2026-02-15
DOI
https://doi.org/10.1002/jso.70213
Citations
1
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
24.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response

Gabriela Bezerra Nobrega, Deise Azevedo Pereira, Milena Martello Cristófalo, EC Baracat et al.
1 citations
Journal of Surgical Oncology
Breast Cancer Treatment Studies
24.82
article

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response

Gabriela Bezerra Nobrega, Deise Azevedo Pereira, Milena Martello Cristófalo, EC Baracat, José Roberto Filassi, Jonathan Yugo Maesaka, Yedda Nunes Reis, José Maria Soares Júnior
article en
1 citations

Abstract

Among TNBC patients treated with neoadjuvant chemotherapy, NpCR occurs more frequently than BpCR. These findings provide a descriptive overview of current response patterns and may inform future research exploring the safety of omitting axillary surgical evaluation. Factors beyond tumor subtype likely influence response patterns, indicating the need for further research to identify predictive biomarkers and optimize treatment strategies.

Journal of Surgical Oncology
Instituto do Câncer do Estado de São Paulo (BR), Memorial Hospital (US)
Good health and well-being
Openalex Percentile: Top 1%
Breast Cancer Treatment Studies
24.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.